Adult liver progenitor cells for the treatment of acute exacerbation of chronic liver failure

摘要

The present inventionComposition of human adult liver derived progenitor cells such as human liver derived progenitor cells (halpc)Acute exacerbation of chronic liver failureWith regard to use for the treatment of patients with risk of developing ACLFTreatmentIncluding the step of administering a composition containing a dose of 25-2.5 million doses of precursors to 1 kg of body weight per kilogram;The composition isSubstantially no effective amount of anticoagulant is includedThe patient does not receive the combined treatment using the anticoagulant.